From Proteopedia
(Difference between revisions)
proteopedia linkproteopedia link
|
|
| Line 1: |
Line 1: |
| - | [[Image:1ttr.gif|left|200px]] | + | {{Seed}} |
| | + | [[Image:1ttr.png|left|200px]] |
| | | | |
| | <!-- | | <!-- |
| Line 9: |
Line 10: |
| | {{STRUCTURE_1ttr| PDB=1ttr | SCENE= }} | | {{STRUCTURE_1ttr| PDB=1ttr | SCENE= }} |
| | | | |
| - | '''TRANSTHYRETIN-V/122/I CARDIOMYOPATHIC MUTANT'''
| + | ===TRANSTHYRETIN-V/122/I CARDIOMYOPATHIC MUTANT=== |
| | | | |
| | | | |
| - | ==Overview==
| + | <!-- |
| - | The Val122Ile mutant transthyretin (TTR Ile122) is an amyloidogenic protein which has been described as the major protein component of amyloid fibrils isolated from patients with familial amyloidotic cardiomyopathy (FAC), a disease characterized by cardiac failure and amyloid deposits in the heart. The reasons for the deposition of TTR are still unknown and it is conceivable that a conformational alteration, resulting from the mutation, is fundamental for amyloid formation. The three-dimensional structure of TTR Ile122 was determined and refined to a crystallographic R factor of 15.8% at 1.9 A resolution. The r.m.s. deviation from ideality in bond distances is 0.019 A and in angle-bonded distances is 0.027 A. The presence of two crystallographically independent monomers in the asymmetric unit allowed additional means of estimation of atomic coordinate error. The structure of the mutant is essentially identical to that of the wild-type transthyretin (TTR). The largest deviations occur in surface loops and in the region of the substitution. The protein is a tetramer composed of identical subunits; each monomer has two four-stranded beta-sheets which are extended to eight-stranded beta-sheets when two monomers associate through hydrogen bonds forming a dimer, which is the crystallographic asymmetric unit. The replacement of valine for isoleucine introduces very small alterations in relation to the wild-type protein; nevertheless they seem to confirm a tendency for a less stable tetrameric structure. This would support the idea that the tetrameric structure might be disrupted in amyloid fibrils. | + | The line below this paragraph, {{ABSTRACT_PUBMED_15299606}}, adds the Publication Abstract to the page |
| | + | (as it appears on PubMed at http://www.pubmed.gov), where 15299606 is the PubMed ID number. |
| | + | --> |
| | + | {{ABSTRACT_PUBMED_15299606}} |
| | | | |
| | ==About this Structure== | | ==About this Structure== |
| Line 27: |
Line 31: |
| | [[Category: Retinol-binding]] | | [[Category: Retinol-binding]] |
| | [[Category: Vitamin some]] | | [[Category: Vitamin some]] |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 10:21:14 2008'' | + | |
| | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 23:53:32 2008'' |
Revision as of 20:53, 28 July 2008
Template:STRUCTURE 1ttr
TRANSTHYRETIN-V/122/I CARDIOMYOPATHIC MUTANT
Template:ABSTRACT PUBMED 15299606
About this Structure
1TTR is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Structure of the Val122Ile variant transthyretin - a cardiomyopathic mutant., Damas AM, Ribeiro S, Lamzin VS, Palha JA, Saraiva MJ, Acta Crystallogr D Biol Crystallogr. 1996 Sep 1;52(Pt 5):966-72. PMID:15299606
Page seeded by OCA on Mon Jul 28 23:53:32 2008
